Piracetam for dementia or cognitive impairment - Wikidata - wikimedia - TriplyDB

Piracetam for dementia or cognitive impairment

Piracetam for dementia or cognitive impairment

http://www.wikidata.org/entity/Q24247459

about

Q33908972 Q57692851

sameAs

Huperzine A for vascular dementia Alternative medicine and Alzheimer disease Increased EEG current-source density in the high Beta frequency band induced by levetiracetam adjunctive therapy in refractory partial epilepsy.Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.Rationale and design of a double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of nimodipine in preventing cognitive impairment in ischemic cerebrovascular events (NICE)Therapeutic approaches to age-associated neurocognitive disorders Treatment of vascular dementia. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology.

P2860

Q24241186-489FC7CF-D49D-4A35-AB99-4B0916707853 Q28751860-E0082DDB-F703-419F-B91A-640514E690C8 Q33590745-BC57166B-0810-4E0C-9052-38DA49E5B197 Q33967781-C1E41232-3AB5-4DF4-89A4-CE94A61F439F Q34403971-D0749C81-C45E-4064-9CEF-3FAE12063229 Q35236387-1207B375-9282-4111-96E7-D80B160B3429 Q47128027-59C60A7A-AA31-4AD5-A32D-B4BBA65D41F7

P2860

Piracetam for dementia or cognitive impairment

http://www.wikidata.org/entity/Q24247459

description

2001 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Piracetam for dementia or cognitive impairment

@ast

Piracetam for dementia or cognitive impairment

@en

Piracetam for dementia or cognitive impairment

@en-gb

Piracetam for dementia or cognitive impairment

@nl

type

label

Piracetam for dementia or cognitive impairment

@ast

Piracetam for dementia or cognitive impairment

@en

Piracetam for dementia or cognitive impairment

@en-gb

Piracetam for dementia or cognitive impairment

@nl

altLabel

Piracetam for dementia or cognitive impairment.

@en

prefLabel

Piracetam for dementia or cognitive impairment

@ast

Piracetam for dementia or cognitive impairment

@en

Piracetam for dementia or cognitive impairment

@en-gb

Piracetam for dementia or cognitive impairment

@nl

P1433

Q24247459-051DFD07-74E6-4456-BA2D-B95BFF03A00F

P1476

Q24247459-3906AF1F-A53A-4F96-8048-B9AD68C6E9A1

Q24247459-4A853569-2BD9-4FDD-84F4-16CDC3B06194

P2093

Q24247459-09064F74-F19D-475C-8FCE-B354F27E7134

Q24247459-36A0FCB7-B0B3-48B6-9B5F-DE4614886DD5

Q24247459-499D7417-A20A-4F07-B2BF-4955F0B5FA9A

Q24247459-6CB40B1D-461A-4E6C-9226-14971E28E4FB

Q24247459-FAEFBDD6-1E3D-408A-B7E8-6C8D2CC00024

P2860

Q24247459-14297849-FFA9-41B2-863A-25CD590771C3

Q24247459-16929CCF-CE05-4F78-952C-627E881FA4C6

Q24247459-1FB9FB97-0724-48E2-84AB-499739AD9143

Q24247459-27092BA4-88EB-423A-8B7C-276B73FF97CC

Q24247459-28475B5F-A17D-4AE1-BF5D-34E05D3F2A1F

Q24247459-2BA7197A-C35B-4A93-B1AA-CD21DCC96302

Q24247459-3D228C42-8F94-45EF-8360-3A977878BE33

Q24247459-4A1AF87D-8BBC-4B36-B91F-51F4D16135A9

Q24247459-5A774D9A-9A50-4504-94B3-23550C662F32

Q24247459-5C5005BE-FDB6-4C07-A24D-534FEC96C291

P304

Q24247459-31CCE03D-63DC-4EA2-92B8-ED581EFB2DC4

P31

Q24247459-4265E605-801C-4FE3-8D47-B34EA183658B

P356

Q24247459-64E64765-7D3B-4456-82DF-8A927CFFCEF9

P407

Q24247459-97E0D8BC-55E0-4C59-B528-167EF4EF4DF6

P433

Q24247459-C21D19D3-8D6E-448C-AD4B-50005BE5CEE4

P577

Q24247459-59AE857F-E4EA-49B7-8BDF-4E04FC31995C

Q24247459-83CF8538-699F-462C-841D-183173E5BFA3

Q24247459-F78356E6-2CE0-4490-BB20-AB902E697423

P698

Q24247459-62AEBCF1-45B8-4D76-8B5D-4566854D04BA

Q24247459-C2A0E25B-FB2D-4160-AEAE-78C6EF955464

P921

Q24247459-239A9D18-3754-4BD7-B9CB-77C46833879C

P356

14651858.CD001011

P1433

Cochrane Database of Systematic Reviews

P1476

Piracetam for dementia or cognitive impairment

@en

Piracetam for dementia or cognitive impairment.

@en

P2093

G Grimley Evans

http://www.w3.org/2001/XMLSchema#string

J Grimley Evans

http://www.w3.org/2001/XMLSchema#string

John Grimley Evans

http://www.w3.org/2001/XMLSchema#string

L Flicker

http://www.w3.org/2001/XMLSchema#string

Leon Flicker

http://www.w3.org/2001/XMLSchema#string

P2860

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Design and Study of Piracetam-like Nootropics, Controversial Members of the Problematic Class of Cognition-Enhancing Drugs

Clinical and biochemical responses to therapy in Alzheimer's disease and multi-infarct dementia

Piracetam in elderly psychiatric patients with mild diffuse cerebral impairment.

Sequelae of closed craniocerebral trauma and the efficacy of piracetam in its treatment in adolescents.

Piracetam in alcoholic psychoses: a double-blind, crossover, placebo controlled study.

Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders.

Cholinergic approaches to the treatment of Alzheimer's disease.

P304

CD001011

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/14651858.CD001011

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P577

2000-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2001-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2004-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10796585

http://www.w3.org/2001/XMLSchema#string

11405971

http://www.w3.org/2001/XMLSchema#string

P921